Screener
Eligibility screening
Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
38 US sites in AL, AR, CA, CO +20
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.